The Combined Antibiotic Therapy for Carbapenem Resistant Klebsiella Pneumoniae
Status:
Unknown status
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
The infection of carbapenem resistant klebsiella pneumoniae (CRKP) is increasingly
serious.Based on the early experimental basis and relevant research background,this study
intends to separate and purify the CRKP from the bronchoalveolar lavage fluid (BALF) of the
clinical patients.Designed by checkerboard assay and time-kill assay(TKA)，this study can
explore the best combination therapy based on carbapenems.